CROSS COUNTRY HEALTHCARE INC

Listed Company

CCRNCIK 0001141103NasdaqAcceleratedServices-Help Supply ServicesDelawareFY ends Dec 31

Period

FY 2025

Revenue

$1.05B

Net Income

$-94.85M

Total Assets

$448.95M

Equity

$322.82M

Shares Out

32.33M

Op. Cash Flow

$48.25M

CCRN$13.24+5.50% · past yearDBEQ Basic

Daily closing prices

Business

Cross Country Healthcare is a healthcare workforce solutions company that delivers an AI-powered digital platform and staffing services to help health systems optimize their labor ecosystem. The company places nurses, allied health professionals, physicians, and other healthcare workers on travel, per diem, and permanent assignments, and operates Intellify®, a cloud-based vendor management system. It serves acute and non-acute care hospitals, outpatient clinics, physician practices, PACE programs, schools, and other healthcare providers through two operating segments: Nursing and Allied Staffing, and Physician Staffing.

Summary from 10-K filed 2026-03-09

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue from services	1,054	1,344	2,020	2,803	1,677
Direct operating expenses	841	1,070	1,569	2,179	1,302
Selling, general and administrative expenses	201	233	300	324	216
Credit loss (credit) expense	−441,000	21	15	10	5
Depreciation and amortization	17	18	18	13	10
Acquisition and integration-related (income) costs	−3	4	59,000	726,000	1
Restructuring costs	4	4	3	2	3
Legal and other losses	3	7	1	0	—
Impairment charges	78	3	719,000	6	2
Total operating expenses	1,139	1,361	1,907	2,534	1,537
(Loss) income from operations	−84	−17	113	270	139
Interest expense	2	2	8	14	—
Loss on early extinguishment of debt	0	0	2	4	0
Interest income	−3	−2	0	0	—
Other expense (income), net	9,000	−605,000	85,000	−1	−770,000
(Loss) income before income taxes	−84	−16	103	253	133
Income tax expense (benefit)	11	−2	30	67	1
Net (loss) income attributable to common shareholders	−95	−15	73	186	132
Unrealized foreign currency translation (loss) income, net of tax	−119,000	−56,000	2,000	−94,000	−13,000
Comprehensive income (loss) attributable to common stockholders	−95	−15	73	186	132
Net (loss) income per share attributable to common stockholders - Basic (in usd per share)	−2.93	−0.44	2.07	5.02	3.6
Net (loss) income per share attributable to common stockholders - Diluted (in usd per share)	−2.93	−0.44	2.05	4.95	3.53
Basic (in shares)	32	33	35	37	37
Diluted (in shares)	32	33	35	38	37

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	109	82	17	4	1
Accounts receivable, net of allowances of $9,112 in 2025 and $9,301 in 2024	168	223	372	642	494
Income taxes receivable	4	10	9	13	0
Prepaid expenses	8	8	8	11	8
Insurance recovery receivable	5	9	9	7	5
Other current assets	1	3	2	1	638,000
Total current assets	294	335	417	677	508
Property and equipment, net	28	29	27	20	16
Operating lease right-of-use assets	2	2	3	3	7
Goodwill	64	135	135	163	119
Other intangible assets, net	28	42	54	45	48
Deferred tax assets	0	8	6	7	12
Insurance recovery receivable	15	21	26	23	14
Cloud computing	14	11	6	4	—
Deferred compensation asset	3	3	—	—	—
Other assets	2	3	7	7	8
Total assets	449	589	681	950	733
Accounts payable and accrued expenses	46	65	93	193	110
Accrued compensation and benefits	28	48	52	73	66
Operating lease liabilities	1	2	3	4	4
Earnout liability	0	4	7	8	8
Other current liabilities	2	1	2	2	1
Total current liabilities	78	120	156	279	200
Operating lease liabilities	1	2	3	5	11
Deferred tax liabilities	3	566,000	—	—	190,000
Accrued claims	30	34	35	36	25
Uncertain tax positions	10	10	11	8	9
Deferred compensation liability	3	3	—	—	—
Other liabilities	2	74,000	4	4	5
Total liabilities	126	170	213	498	435
Commitments and contingencies	—	—	—	—	—
Common stock$0.0001 par value; 100,000,000 shares authorized; 31,721,280 and 32,277,395 shares issued and outstanding at December 31, 2025 and 2024, respectively	3,000	3,000	4,000	4,000	4,000
Additional paid-in capital	201	202	236	293	322
Accumulated other comprehensive loss	−2	−1	−1	−1	−1
Retained earnings	123	218	233	160	−23
Total stockholders' equity	323	419	468	451	294
Total liabilities and stockholders' equity	449	589	681	950	733

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Provision for allowances	−999,000	21	17	15	6
Deferred income tax expense (benefit)	10	−2	1	5	−10
Non-cash lease expense	1	992,000	1	2	2
Equity-related severance and compensation	7	6	7	7	7
Other non-cash costs	755,000	99,000	1	199,000	2
Accounts receivable	57	128	251	−153	−318
Prepaid expenses and other assets	−2	−5	268,000	−7	−3
Income taxes	7	−2	7	−21	7
Accounts payable and accrued expenses	−35	−30	−127	83	83
Operating lease liabilities	−2	−3	−4	−5	−7
Other	6	−890,000	−191,000	−639,000	503,000
Net cash provided by operating activities	48	120	248	134	−86
Acquisition-related settlements	0	0	199,000	94,000	1
Purchases of property and equipment	−8	−9	−14	−9	−7
Net cash used in investing activities	−8	−9	−14	−44	−34
Principal payments on term loan	0	0	−74	−100	−688,000
Borrowings under Senior Secured Asset-Based revolving credit facility	1	18	721	1,700	444
Repayments on Senior Secured Asset-Based revolving credit facility	−1	−18	−798	−1,632	−488
Cash paid for shares withheld for taxes	−2	−3	−5	−5	−2
Payment of contingent consideration	−4	−7	−8	−8	0
Stock repurchase and retirement	−7	−37	−58	−35	0
Other	0	0	−508,000	−1	−255,000
Net cash used in financing activities	−13	−47	−221	−88	119
Effect of exchange rate changes on cash	21,000	−14,000	8,000	−9,000	6,000
Change in cash and cash equivalents	27	65	13	3	−564,000
Interest paid	1	1	8	13	6
Income taxes (received) paid	−6	2	22	—	—

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro

Frequently asked questions

What is CROSS COUNTRY HEALTHCARE INC's CIK number?

CROSS COUNTRY HEALTHCARE INC's SEC CIK number is 0001141103 (1141103). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.

Where can I find CROSS COUNTRY HEALTHCARE INC's SEC filings?

All of CROSS COUNTRY HEALTHCARE INC's EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.

When did CROSS COUNTRY HEALTHCARE INC last report earnings?

CROSS COUNTRY HEALTHCARE INC (CCRN) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001628280-26-032217). This is CROSS COUNTRY HEALTHCARE INC's most recent earnings filing of record — not a forecast of its next earnings date.

What is CROSS COUNTRY HEALTHCARE INC's most recent earnings 8-K?

CROSS COUNTRY HEALTHCARE INC's latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001628280-26-032217. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.

View CROSS COUNTRY HEALTHCARE INC's latest earnings 8-K →
Look up any company's CIK number →